(ADI) Analog Devices - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0326541051
Stock:
Total Rating 72
Risk 86
Buy Signal 1.27
| Risk 5d forecast | |
|---|---|
| Volatility | 27.5% |
| Relative Tail Risk | -3.43% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.21 |
| Alpha | 28.06 |
| Character TTM | |
|---|---|
| Beta | 1.578 |
| Beta Downside | 2.252 |
| Drawdowns 3y | |
|---|---|
| Max DD | 32.20% |
| CAGR/Max DD | 0.82 |
EPS (Earnings per Share)
Revenue
Risks
Fundamental:
P/E ratio: 78.0899
Description: ADI Analog Devices
Analog Devices, Inc. engages in the design, manufacture, testing, and marketing of integrated circuits (ICs), software, and subsystems products in the United States, rest of North and South America, Europe, Japan, China, and rest of Asia. It provides data converter products, which translate real-world analog signals into digital data, as well as translates digital data into analog signals; power management and reference products for power conversion, driver monitoring, sequencing, and energy management applications in the automotive, communications, industrial, and consumer markets; and power ICs that include performance, integration, and software design simulation tools for accurate power supply designs. The company also offers amplifiers to condition analog signals; and radio frequency and microwave ICs to support cellular infrastructure; and micro-electro-mechanical systems technology solutions, including accelerometers used to sense acceleration, gyroscopes for sense rotation, inertial measurement units to sense multiple degrees of freedom, and broadband switches for radio and instrument systems, as well as isolators. In addition, it provides digital signal processing and system products for numeric calculations. The company serves clients in the industrial, automotive, consumer, instrumentation, aerospace, defense and healthcare, and communications markets through a direct sales force, third-party distributors, and independent sales representatives, as well as online. The company was incorporated in 1965 and is headquartered in Wilmington, Massachusetts.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 2.71b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 2.86 > 1.0 |
| NWC/Revenue: 27.83% < 20% (prev 29.58%; Δ -1.75% < -1%) |
| CFO/TA 0.11 > 3% & CFO 5.05b > Net Income 2.71b |
| Net Debt (5.78b) to EBITDA (5.52b): 1.05 < 3 |
| Current Ratio: 1.76 > 1.5 & < 3 |
| Outstanding Shares: last quarter (491.7m) vs 12m ago -1.41% < -2% |
| Gross Margin: 62.84% > 18% (prev 0.57%; Δ 6227 % > 0.5%) |
| Asset Turnover: 24.50% > 50% (prev 19.47%; Δ 5.04% > 0%) |
| Interest Coverage Ratio: 10.80 > 6 (EBITDA TTM 5.52b / Interest Expense TTM 328.8m) |
Altman Z'' 2.48
| A: 0.07 (Total Current Assets 7.60b - Total Current Liabilities 4.33b) / Total Assets 47.99b |
| B: 0.23 (Retained Earnings 10.89b / Total Assets 47.99b) |
| C: 0.07 (EBIT TTM 3.55b / Avg Total Assets 47.98b) |
| D: 0.76 (Book Value of Equity 10.82b / Total Liabilities 14.20b) |
| Altman-Z'' Score: 2.48 = A |
Beneish M -3.08
| DSRI: 0.91 (Receivables 1.36b/1.19b, Revenue 11.76b/9.34b) |
| GMI: 0.91 (GM 62.84% / 57.16%) |
| AQI: 0.95 (AQ_t 0.77 / AQ_t-1 0.81) |
| SGI: 1.26 (Revenue 11.76b / 9.34b) |
| TATA: -0.05 (NI 2.71b - CFO 5.05b) / TA 47.99b) |
| Beneish M-Score: -3.08 (Cap -4..+1) = AA |
What is the price of ADI shares?
As of February 27, 2026, the stock is trading at USD 354.35 with a total of 4,661,124 shares traded.
Over the past week, the price has changed by +2.62%, over one month by +16.56%, over three months by +37.87% and over the past year by +54.11%.
Over the past week, the price has changed by +2.62%, over one month by +16.56%, over three months by +37.87% and over the past year by +54.11%.
Is ADI a buy, sell or hold?
Analog Devices has received a consensus analysts rating of 4.13.
Therefore, it is recommended to buy ADI.
- StrongBuy: 16
- Buy: 5
- Hold: 9
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the ADI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 382.4 | 7.9% |
| Analysts Target Price | 382.4 | 7.9% |
ADI Fundamental Data Overview February 25, 2026
P/E Trailing = 78.0899
P/E Forward = 25.7069
P/S = 14.8307
P/B = 3.488
P/EG = 0.824
Revenue TTM = 11.76b USD
EBIT TTM = 3.55b USD
EBITDA TTM = 5.52b USD
Long Term Debt = 8.15b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.44b USD (from shortTermDebt, last quarter)
Debt = 8.68b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.78b USD (from netDebt column, last quarter)
Enterprise Value = 178.99b USD (174.36b + Debt 8.68b - CCE 4.05b)
Interest Coverage Ratio = 10.80 (Ebit TTM 3.55b / Interest Expense TTM 328.8m)
EV/FCF = 39.25x (Enterprise Value 178.99b / FCF TTM 4.56b)
FCF Yield = 2.55% (FCF TTM 4.56b / Enterprise Value 178.99b)
FCF Margin = 38.79% (FCF TTM 4.56b / Revenue TTM 11.76b)
Net Margin = 23.02% (Net Income TTM 2.71b / Revenue TTM 11.76b)
Gross Margin = 62.84% ((Revenue TTM 11.76b - Cost of Revenue TTM 4.37b) / Revenue TTM)
Gross Margin QoQ = 64.71% (prev 63.13%)
Tobins Q-Ratio = 3.73 (Enterprise Value 178.99b / Total Assets 47.99b)
Interest Expense / Debt = 0.99% (Interest Expense 86.3m / Debt 8.68b)
Taxrate = 12.16% (115.0m / 945.9m)
NOPAT = 3.12b (EBIT 3.55b * (1 - 12.16%))
Current Ratio = 1.76 (Total Current Assets 7.60b / Total Current Liabilities 4.33b)
Debt / Equity = 0.26 (Debt 8.68b / totalStockholderEquity, last quarter 33.79b)
Debt / EBITDA = 1.05 (Net Debt 5.78b / EBITDA 5.52b)
Debt / FCF = 1.27 (Net Debt 5.78b / FCF TTM 4.56b)
Total Stockholder Equity = 34.17b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.64% (Net Income 2.71b / Total Assets 47.99b)
RoE = 7.92% (Net Income TTM 2.71b / Total Stockholder Equity 34.17b)
RoCE = 8.39% (EBIT 3.55b / Capital Employed (Equity 34.17b + L.T.Debt 8.15b))
RoIC = 7.35% (NOPAT 3.12b / Invested Capital 42.46b)
WACC = 11.22% (E(174.36b)/V(183.04b) * Re(11.73%) + D(8.68b)/V(183.04b) * Rd(0.99%) * (1-Tc(0.12)))
Discount Rate = 11.73% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.71%
[DCF] Terminal Value 67.08% ; FCFF base≈4.01b ; Y1≈3.98b ; Y5≈4.14b
[DCF] Fair Price = 80.02 (EV 44.88b - Net Debt 5.78b = Equity 39.10b / Shares 488.6m; r=11.22% [WACC]; 5y FCF grow -1.58% → 2.90% )
EPS Correlation: -41.74 | EPS CAGR: 0.66% | SUE: 2.45 | # QB: 1
Revenue Correlation: -32.32 | Revenue CAGR: 1.65% | SUE: 1.07 | # QB: 8
EPS next Quarter (2026-04-30): EPS=2.90 | Chg7d=+0.441 | Chg30d=+0.459 | Revisions Net=+23 | Analysts=27
EPS current Year (2026-10-31): EPS=11.46 | Chg7d=+1.449 | Chg30d=+1.498 | Revisions Net=+25 | Growth EPS=+47.1% | Growth Revenue=+26.8%
EPS next Year (2027-10-31): EPS=12.84 | Chg7d=+1.352 | Chg30d=+1.435 | Revisions Net=+24 | Growth EPS=+12.1% | Growth Revenue=+9.0%
[Analyst] Revisions Ratio: +1.00 (23 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 10.4% (Discount Rate 11.7% - Earnings Yield 1.3%)
[Growth] Growth Spread = +22.5% (Analyst 33.0% - Implied 10.4%)
P/E Forward = 25.7069
P/S = 14.8307
P/B = 3.488
P/EG = 0.824
Revenue TTM = 11.76b USD
EBIT TTM = 3.55b USD
EBITDA TTM = 5.52b USD
Long Term Debt = 8.15b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.44b USD (from shortTermDebt, last quarter)
Debt = 8.68b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.78b USD (from netDebt column, last quarter)
Enterprise Value = 178.99b USD (174.36b + Debt 8.68b - CCE 4.05b)
Interest Coverage Ratio = 10.80 (Ebit TTM 3.55b / Interest Expense TTM 328.8m)
EV/FCF = 39.25x (Enterprise Value 178.99b / FCF TTM 4.56b)
FCF Yield = 2.55% (FCF TTM 4.56b / Enterprise Value 178.99b)
FCF Margin = 38.79% (FCF TTM 4.56b / Revenue TTM 11.76b)
Net Margin = 23.02% (Net Income TTM 2.71b / Revenue TTM 11.76b)
Gross Margin = 62.84% ((Revenue TTM 11.76b - Cost of Revenue TTM 4.37b) / Revenue TTM)
Gross Margin QoQ = 64.71% (prev 63.13%)
Tobins Q-Ratio = 3.73 (Enterprise Value 178.99b / Total Assets 47.99b)
Interest Expense / Debt = 0.99% (Interest Expense 86.3m / Debt 8.68b)
Taxrate = 12.16% (115.0m / 945.9m)
NOPAT = 3.12b (EBIT 3.55b * (1 - 12.16%))
Current Ratio = 1.76 (Total Current Assets 7.60b / Total Current Liabilities 4.33b)
Debt / Equity = 0.26 (Debt 8.68b / totalStockholderEquity, last quarter 33.79b)
Debt / EBITDA = 1.05 (Net Debt 5.78b / EBITDA 5.52b)
Debt / FCF = 1.27 (Net Debt 5.78b / FCF TTM 4.56b)
Total Stockholder Equity = 34.17b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.64% (Net Income 2.71b / Total Assets 47.99b)
RoE = 7.92% (Net Income TTM 2.71b / Total Stockholder Equity 34.17b)
RoCE = 8.39% (EBIT 3.55b / Capital Employed (Equity 34.17b + L.T.Debt 8.15b))
RoIC = 7.35% (NOPAT 3.12b / Invested Capital 42.46b)
WACC = 11.22% (E(174.36b)/V(183.04b) * Re(11.73%) + D(8.68b)/V(183.04b) * Rd(0.99%) * (1-Tc(0.12)))
Discount Rate = 11.73% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.71%
[DCF] Terminal Value 67.08% ; FCFF base≈4.01b ; Y1≈3.98b ; Y5≈4.14b
[DCF] Fair Price = 80.02 (EV 44.88b - Net Debt 5.78b = Equity 39.10b / Shares 488.6m; r=11.22% [WACC]; 5y FCF grow -1.58% → 2.90% )
EPS Correlation: -41.74 | EPS CAGR: 0.66% | SUE: 2.45 | # QB: 1
Revenue Correlation: -32.32 | Revenue CAGR: 1.65% | SUE: 1.07 | # QB: 8
EPS next Quarter (2026-04-30): EPS=2.90 | Chg7d=+0.441 | Chg30d=+0.459 | Revisions Net=+23 | Analysts=27
EPS current Year (2026-10-31): EPS=11.46 | Chg7d=+1.449 | Chg30d=+1.498 | Revisions Net=+25 | Growth EPS=+47.1% | Growth Revenue=+26.8%
EPS next Year (2027-10-31): EPS=12.84 | Chg7d=+1.352 | Chg30d=+1.435 | Revisions Net=+24 | Growth EPS=+12.1% | Growth Revenue=+9.0%
[Analyst] Revisions Ratio: +1.00 (23 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 10.4% (Discount Rate 11.7% - Earnings Yield 1.3%)
[Growth] Growth Spread = +22.5% (Analyst 33.0% - Implied 10.4%)